Proteomic Profiling of Plasma in Huntington's Disease Reveals Neuroinflammatory Activation and Biomarker Candidates-Reference-Cited by-同舟云学术

Proteomic Profiling of Plasma in Huntington's Disease Reveals Neuroinflammatory Activation and Biomarker Candidates

Published:2007-06-07 Issue:7 Volume:6 Page:2833-2840
ISSN:1535-3893
Container-title:Journal of Proteome Research
language:en
Short-container-title:J. Proteome Res.

Author:

Dalrymple Annette¹,Wild Edward J.¹,Joubert Richard¹,Sathasivam Kirupa¹,Björkqvist Maria¹,Petersén Åsa¹,Jackson Graham S.¹,Isaacs Jeremy D.¹,Kristiansen Mark¹,Bates Gillian P.¹,Leavitt Blair R.¹,Keir Geoff¹,Ward Malcolm¹,Tabrizi Sarah J.¹

Affiliation:

1. Proteome Sciences PLC, Cobham, Surrey, United Kingdom, Department of Neurodegenerative Disease, Institute of Neurology, London, United Kingdom, King's College London School of Medicine, Guy's Hospital, London, United Kingdom, Neuronal Survival Unit, Department of Experimental Medical Science, Wallenberg Neuroscience Center, Lund, Sweden, Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, BC, Canada, and Neuroimmunology Laboratory, National Hospital for Neurology...

Publisher

American Chemical Society (ACS)

Subject

General Chemistry,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/pr0700753

Reference37 articles.

1. Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease

2. Activated Immune System in Patients with Huntington's Disease

3. Pharmaceutical, cellular and genetic therapies for Huntington's disease

Cited by 197 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunobiology and Immunotherapies in Huntington's Disease;Advances in Diagnostics and Immunotherapeutics for Neurodegenerative Diseases;2024-07-28

2. The complement system in neurodegenerative and inflammatory diseases of the central nervous system;Frontiers in Neurology;2024-07-03

3. Challenges and Future Perspectives in Modeling Neurodegenerative Diseases Using Organ‐on‐a‐Chip Technology;Advanced Science;2024-06-23

4. Inflammation and Huntington’s disease – a neglected therapeutic target?;Expert Opinion on Investigational Drugs;2024-05-03

5. Mutant huntingtin protein induces MLH1 degradation, DNA hyperexcision, and cGAS–STING-dependent apoptosis;Proceedings of the National Academy of Sciences;2024-03-18